An over-the-counter supplement costing as little as 20p is being linked to better heart health and could reduce fatigue, aches, and cognitive decline for the millions of people taking statins. Coenzyme Q10 (CoQ10) is already used by some statin users to manage side effects.
How CoQ10 interacts with statins
Statins work by blocking an enzyme involved in cholesterol production, which also reduces the body's natural production of co-enzyme Q10. A 2025 research review found that taking CoQ10 alongside statins reduced muscle pain.
Around eight million people in the UK take statins to lower cholesterol and prevent cardiovascular disease. CoQ10 is already the fourth most popular supplement in the USA, and it is now believed the pills could have even more health benefits.
Natural production and dietary sources
CoQ10 is sold strictly over the counter as a food supplement rather than a licensed medicine. The body naturally makes 500mg of CoQ10 every day, although the amount declines with age. It can also be obtained from food such as meat, oily fish, nuts, spinach, and broccoli.
Stephen Bailey, a reader in human and exercise physiology at Loughborough University who researches CoQ10, told MailOnline: "CoQ10 could protect cells from oxidative damage, which is being investigated in reducing age-related cognitive decline – although results so far are inconclusive." A review of 24 trials in the British Journal of Nutrition found some evidence CoQ10 supplements could reduce fatigue.
Who takes CoQ10 supplements
Around 20 million UK adults take at least one dietary supplement daily, with CoQ10 representing a smaller, targeted niche within that group - primarily bought by adults over 40, people taking statins, and those seeking support for energy, fertility, or cardiovascular health.
Major clinical trials, such as the landmark Q-SYMBIO trial, and systematic reviews show that taking CoQ10 alongside standard heart failure medications significantly reduces major adverse cardiovascular events, hospitalisations, and mortality in patients with chronic heart failure. UK bodies like NICE do not yet recommend it for routine NHS prescribing because larger, multi-centre trials are still needed to confirm long-term dosing protocols.
Because CoQ10 has a very high safety profile, many cardiologists consider it a harmless "worth-a-try" option for patients struggling with statin aches, even though clinical guidelines do not endorse it. Multiple clinical trials and meta-analyses indicate that CoQ10 can reduce the frequency and duration of migraines in adults (typically by about 1 to 1.5 headache days per month), though it does not significantly reduce the severity of a migraine once it starts. Both the American Academy of Neurology and the Canadian Headache Society recognise it as a reasonable preventative option.